NDC 52652-6001

FLEQSUVY

Baclofen

FLEQSUVY is a Oral Suspension in the Human Prescription Drug category. It is labeled and distributed by Azurity Pharmaceuticals, Inc.. The primary component is Baclofen.

Product ID52652-6001_9076d6ce-bbc2-4a9f-9cb9-2de1b675b9aa
NDC52652-6001
Product TypeHuman Prescription Drug
Proprietary NameFLEQSUVY
Generic NameBaclofen
Dosage FormSuspension
Route of AdministrationORAL
Marketing Start Date2022-02-07
Marketing CategoryNDA /
Application NumberNDA215602
Labeler NameAzurity Pharmaceuticals, Inc.
Substance NameBACLOFEN
Active Ingredient Strength5 mg/mL
Pharm ClassesGABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 52652-6001-1

1 BOTTLE in 1 CARTON (52652-6001-1) > 120 mL in 1 BOTTLE
Marketing Start Date2022-02-07
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "FLEQSUVY" or generic name "Baclofen"

NDCBrand NameGeneric Name
0115-1010BaclofenBaclofen
0115-1011BaclofenBaclofen
0115-1012BaclofenBaclofen
0172-4096BaclofenBaclofen
0172-4097BaclofenBaclofen
0527-1330Baclofenbaclofen
0527-1333Baclofenbaclofen
0527-1337Baclofenbaclofen
0603-2406BaclofenBaclofen
0603-2407BaclofenBaclofen
0615-3541BaclofenBaclofen
0615-3542BaclofenBaclofen
0615-8411BaclofenBaclofen
0615-8412BaclofenBaclofen

Trademark Results [FLEQSUVY]

Mark Image

Registration | Serial
Company
Trademark
Application Date
FLEQSUVY
FLEQSUVY
90752265 not registered Live/Pending
Azurity Pharmaceuticals, Inc.
2021-06-03

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.